Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm

International Journal of Antimicrobial Agents

Volumn 32, Issue 6, 2008, Pages 515-518

  Raad, Issam I ^a   Hachem, Ray Y ^a   Hanna, Hend A ^a   Fang, Xiang ^a   Jiang, Ying ^a   Dvorak, Tanya ^a   Sherertz, Robert J ^b   Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Antifungal activity; Biofilms; Candida; Catheter lock solution; EDTA; Infection

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; EDETIC ACID; SILICONE;

ANTIFUNGAL ACTIVITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDEMIA; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DRUG EFFICACY; FUNGAL COLONIZATION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; BIOFILMS; CANDIDA; CANDIDA ALBICANS; CATHETER-RELATED INFECTIONS; CHELATING AGENTS; COLONY COUNT, MICROBIAL; DRUG SYNERGISM; EDETIC ACID; PHARMACEUTICAL SOLUTIONS;

EID: 55249111977     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.06.020     Document Type: Article

References (36)

1. Karabinis A., Hill C., Leclercq B., Tancrède C., Baume D., and Andremont A. Risk factors for candidemia in cancer patients: a case-control study. J Clin Microbiol 26 (1988) 429-432
2. Raad I., Costerton W., Sabharwal U., Sacilowski M., Anaissie E., and Bodey G.P. Ultrastructural analysis of indwelling vascular catheters: quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168 (1993) 400-407
3. Wey S.B., Mori M., Pfaller M.A., Woolson R.F., and Wenzel R.P. Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med 149 (1989) 2349-2353
4. Hawser S.P., and Douglas J. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun 62 (1994) 915-921
5. Shin J.H., Kee S.J., Shin M.G., Kim S.H., Shin D.H., Lee S.K., et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40 (2002) 1244-1248
6. Raad I., Hanna H., Boktour M., Girgawy E., Danawi H., Mardani M., et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis 38 (2004) 1119-1127
7. Segarra-Newnham M., and Martin-Cooper E.M. Antibiotic lock technique: a review of the literature. Ann Pharmacother 39 (2005) 311-318
8. Kuhn D.M., George T., Chandra J., Mukherjee P.K., and Ghannoum M.A. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46 (2002) 1773-1780
9. Bleyer A.J., Mason L., Russell G., Raad I.I., and Sherertz R.J. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 26 (2005) 520-524
10. Gil M.L., Casanoa M., and Martinez J.P. Changes in the cell wall glycoprotein composition of Candida albicans associated to the inhibition of germ tube formation by EDTA. Arch Microbiol 161 (1994) 489-494
11. Percival S.L., Kite P., Eastwood K., Murga R., Carr J., Arduino M.J., et al. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26 (2005) 515-519
12. Raad I., Chatzinikolaou I., Chaiban G., Hanna H., Hachem R., Dvorak T., et al. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 47 (2003) 3580-3585
13. Raad I., Hanna H., Dvorak T., Chaiban G., and Hachem R. Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm. Antimicrob Agents Chemother 1 (2007) 78-83
14. Bassetti M., Trecarichi E.M., Righi E., Sanguinetti M., Bisio F., Posteraro B., et al. Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diagn Microbiol Infect Dis 58 (2007) 325-331
15. Beck-Sague C., and Jarvis W.R. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990: National Nosocomial Infections Surveillance System. J Infect Dis 167 (1993) 1247-1251
16. Edmond M.B., Wallace S.E., McClish D.K., Pfaller M.A., Jones R.N., and Wenzel R.P. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29 (1999) 239-244
17. Blumberg H.M., Jarvis W.R., Soucie J.M., Edwards J.E., Patterson J.E., Pfaller M.A., et al. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. Clin Infect Dis 33 (2001) 177-186
18. Kojic E.M., and Darouiche R.O. Comparison of adherence of Candida albicans and Candida parapsilosis to silicone catheters in vitro and in vivo. Clin Microbiol Infect 9 (2003) 684-690
19. Kuhn D.M., and Ghannoum M.A. Candida biofilms: antifungal resistance and emerging therapeutic options. Curr Opin Investig Drugs 5 (2004) 186-197
20. Kumamoto C.A. Candida biofilms. Curr Opin Microbiol 5 (2002) 608-611
21. Mukherjee P.K., and Chandra J. Candida biofilm resistance. Drug Resist Updat 7 (2004) 301-309
22. Mukherjee P.K., Zhou G., Munyon R., and Ghannoum M.A. Candida biofilm: a well-designed protected environment. Med Mycol 43 (2005) 191-208
23. Douglas L.J. Candida biofilms and their role in infection. Trends Microbiol 11 (2003) 30-36
24. Almirante B., Rodríguez D., Park B.J., Cuenca-Estrella M., Planes A.M., Almela M., et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 43 (2005) 1829-1835
25. Hung C.C., Chen Y.C., Chang S.C., Luh K.T., and Hsieh W.C. Nosocomial candidemia in a university hospital in Taiwan. J Formos Med Assoc 95 (1996) 19-28
26. Karlowicz M.G., Hashimoto L.N., Kelly Jr. R.E., and Buescher E.S. Should central venous catheters be removed as soon as candidemia is detected in neonates?. Pediatrics 106 (2000) E63
27. Nguyen M.H., Peacock Jr. J.E., Tanner D.C., Morris A.J., Nguyen M.L., Snydman D.R., et al. Therapeutic approaches in patients with candidemia: evaluation of a multicenter, prospective observational study. Arch Intern Med 144 (1995) 2429-2435
28. Rex J.H., Bennett J.E., Sugar A.M., Pappas P.G., Serody J., Edwards J.E., et al. Intravascular catheter exchange and duration of candidemia. Clin Infect Dis 21 (1995) 994-996
29. Berrington A., and Gould F.K. Use of antibiotic locks to treat colonized central venous catheters. J Antimicrob Chemother 48 (2001) 597-603
30. Rijnders B.J., Van Wijngaerden E., Vandecasteele S.J., Stas M., and Peetermans W.E. Treatment of long-term intravascular catheter-related bacteremia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother 55 (2005) 90-94
31. Benoit J.L., Carandang G., Sitrin M., and Arnow P. Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis 21 (1995) 1286-1288
32. Ramage G., Wickes B.L., and Lopez-Ribot J.L. Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA). Mycopathologia 164 (2007) 301-306
33. Akpolat N.O., Elci S., Atmaca S., Akbayin H., and Gul K. The effects of magnesium, calcium and EDTA on slime production by Staphylococcus epidermidis strains. Folia Microbiol 48 (2003) 649-653
34. Banin E., Brady K.M., and Greenberg E.P. Chelator-induced dispersal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl Environ Microbiol 72 (2006) 2064-2069
35. Kite P., Eastwood K., Sugden S., and Percival S.L. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 42 (2004) 3073-3076
36. Shanks R.M., Donegan N.P., Graber M.L., Buckingham S.E., Zegans M.E., Cheung A.L., et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 73 (2005) 4596-4606